Grow your business safely with LABORATOIRE PHARMACEUTIQUE PHARMATOKA SAS

All the information you need about LABORATOIRE PHARMACEUTIQUE PHARMATOKA SAS to develop and secure your business in France

THE LIST OF BALANCE SHEET : LABORATOIRE PHARMACEUTIQUE PHARMATOKA SAS

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-06-22 Public 2021-12-31 Complete
2021-09-13 Public 2020-12-31 Complete
2021-03-03 Public 2019-12-31 Complete
2019-04-05 Public 2018-09-30 Complete
2017-09-20 Public 2016-12-31 Complete
NameLABORATOIRE PHARMACEUTIQUE PHARMATOKA SAS
Siren809463136
Closing2016-12-31
Registry code 9201
Registration number 40424
Management number2015B01675
Activity code 4646Z
Closing date n-12015-12-31
Duration Fiscal year 12
Duration Fiscal year n-100
Filing date2017-09-20
Modification01 Annual accounts entered with accounting inconsistencies at document source
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address92500 RUEIL MALMAISON
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AB Establishment Expenses 45 682.00 10 010.00 35 673.00 45 682.00
AT Other tangible assets 4 616.00 1 345.00 3 270.00 4 616.00
AV Fixed assets in progress 200 000.00 200 000.00 200 000.00
BJ TOTAL (I) 250 298.00 11 355.00 238 943.00 250 298.00
BX Customers and related accounts 52 920.00 52 920.00 52 920.00
BZ Other receivables 100 388.00 100 388.00 100 388.00
CF Cash and cash equivalents 1 057.00 1 057.00 1 057.00
CH Prepaid expenses 5 577.00 5 577.00 5 577.00
CJ TOTAL (II) 159 942.00 159 942.00 159 942.00
CO Grand total (0 to V) 410 240.00 11 355.00 398 885.00 410 240.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 10 000.00 10 000.00 10 000.00
DH Retained earnings -36 247.00 -36 247.00
DI RESULTS FOR THE YEAR (Profit or Loss) -373 890.00 -36 247.00 -373 890.00
DL TOTAL (I) -400 137.00 -26 247.00 -400 137.00
DV Miscellaneous Loans and Financial Debts (4) 147 038.00 15 000.00 147 038.00
DX Trade payables and related accounts 627 621.00 67 794.00 627 621.00
DY Tax and social security liabilities 24 364.00 1 430.00 24 364.00
EC TOTAL (IV) 799 022.00 84 224.00 799 022.00
EE Grand total (I to V) 398 885.00 57 977.00 398 885.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FD Production sold - goods 52 920.00 52 920.00
FJ Net sales 52 920.00 52 920.00
FQ Other income 1.00
FR Total operating income (I) 52 921.00
FW Other purchases and external expenses 81 123.00
FX Taxes, duties, and similar payments 4 914.00
FY Salaries and Wages 96 354.00
FZ Social Security Contributions 41 355.00
GA Operating Expenses - Depreciation and Amortization 9 940.00
GE Other Expenses 193 072.00
GF Total Operating Expenses (II) 426 757.00
GG - OPERATING RESULT (I - II) -373 836.00
GS Negative differences of foreign exchange 38.00
GU Total financial expenses (VI) 38.00
GV - FINANCIAL INCOME (V - VI) -38.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -373 874.00
4 - Income statement (continued)Amount year NAmount year N-1
HE Exceptional expenses on management operations 17.00 17.00
HH Total exceptional expenses (VIII) 17.00 17.00
HI - EXCEPTIONAL RESULT (VII - VIII) -17.00 -17.00
HL TOTAL REVENUE (I + III + V + VII) 52 922.00 52 922.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 426 812.00 36 247.00 426 812.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -373 890.00 -36 247.00 -373 890.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 42 927.00 213 014.00 42 927.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 41 062.00 10 264.00 41 062.00
I4 DECREASES Grand Total 5 643.00 250 298.00
IN DECREASES Start-up, development, or research expenses 5 643.00 45 682.00
IY DECREASES Total Tangible Fixed Assets 204 616.00
LN ACQUISITIONS Total Tangible Fixed Assets 1 866.00 202 750.00 1 866.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 1 398.00 9 957.00 1 398.00
CY DEPRECIATION Start-up, development, or research expenses 1 087.00 8 922.00 1 087.00
QU DEPRECIATION Total Tangible Fixed Assets 311.00 1 034.00 311.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 627 621.00 627 621.00 627 621.00
8C Staff and Related Accounts 5 339.00 5 339.00 5 339.00
8D Social Security and Other Social Organizations 17 346.00 17 346.00 17 346.00
UX Other trade receivables 52 920.00 52 920.00
VB VAT 100 388.00 100 388.00
VI Group and Associates 147 038.00 147 038.00 147 038.00
VQ Other Taxes, Duties, and Similar Debts 1 679.00 1 679.00 1 679.00
VS Prepaid expenses 5 577.00 5 577.00
VT TOTAL – STATEMENT OF RECEIVABLES 158 885.00 158 885.00 158 885.00
VY TOTAL – STATEMENT OF LIABILITIES 799 022.00 799 022.00 799 022.00

all companies in France

Complete and comprehensive database.